Krystal Biotech (KRYS) PT Raised to $75 at Chardan Capital Markets
Tweet Send to a Friend
Chardan Capital Markets analyst Gbola Amusa raised the price target on Krystal Biotech (NASDAQ: KRYS) to $75.00 (from $57.50) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
